Influenza Vaccine Market Share, Size, Key Players, Industry Overview and Business Opportunities 2022-2027
The Influenza Vaccine Market to reach US$ 9.1 Billion by 2027, exhibiting a CAGR of 7.9% during 2022-2027.
SHERIDAN, WY, USA, November 14, 2022 /EINPresswire.com/ -- According to IMARC Groupโs latest report, titled โ๐๐ง๐๐ฅ๐ฎ๐๐ง๐ณ๐ ๐๐๐๐๐ข๐ง๐ ๐๐๐ซ๐ค๐๐ญ: ๐๐ฅ๐จ๐๐๐ฅ ๐๐ง๐๐ฎ๐ฌ๐ญ๐ซ๐ฒ ๐๐ซ๐๐ง๐๐ฌ, ๐๐ก๐๐ซ๐, ๐๐ข๐ณ๐, ๐๐ซ๐จ๐ฐ๐ญ๐ก, ๐๐ฉ๐ฉ๐จ๐ซ๐ญ๐ฎ๐ง๐ข๐ญ๐ฒ ๐๐ง๐ ๐ ๐จ๐ซ๐๐๐๐ฌ๐ญ ๐๐๐๐-๐๐๐๐โ, the global influenza vaccine market size reached US$ 5.9 Billion in 2021. Looking forward, IMARC Group expects the market to reach US$ 9.1 Billion by 2027, exhibiting a CAGR of 7.9% during 2022-2027.
Influenza is an infection of the throat, lungs, and nose. Common symptoms include head and body aches, cough, fever, and a stuffy or runny nose. Influenza vaccines or flu shots are biological preparations that protect against and prevent severe infections caused by the influenza virus. The vaccines used for influenza are formulated using three different influenza viruses, including influenza type A and B with H3N2 and H1N1 virus strains. These therapeutics are mainly available in inactivated, adjuvant, live attenuated, and recombinant influenza vaccines. Currently, governments of various nations have mandated immunization against influenza among children aged six months to five.
๐๐๐ญ ๐ ๐ ๐ซ๐๐ ๐๐๐ฆ๐ฉ๐ฅ๐ ๐๐จ๐ฉ๐ฒ ๐จ๐ ๐ญ๐ก๐ข๐ฌ ๐๐๐ฉ๐จ๐ซ๐ญ: https://www.imarcgroup.com/influenza-vaccine-market/requestsample
๐๐ง๐๐ฅ๐ฎ๐๐ง๐ณ๐ ๐๐๐๐๐ข๐ง๐ ๐๐๐ซ๐ค๐๐ญ ๐๐ซ๐๐ง๐๐ฌ:
The rising prevalence of influenza and the fueling awareness regarding influenza vaccines are some of the factors primarily driving the market growth. This is further supported by the steadily increasing geriatric population and surging research and development (R&D) activities across the globe. In addition to this, governments of various countries are introducing free seasonal influenza vaccination programs for all age groups, which, in turn, is providing a boost to the market growth. In line with this, key market players are actively working to develop new vaccines with better efficacy, which is accelerating the market growth. Other factors, such as growing healthcare expenditure and rising clinical trials, are creating a positive outlook for the market.
๐๐ฎ๐ฒ ๐๐จ๐ฐ: https://www.imarcgroup.com/checkout?id=4206&method=1
Influenza Vaccine Market 2022-2027 Competitive Analysis and Segmentation:
Competitive Landscape with Key Players:
The competitive landscape of the influenza vaccine market has been studied in the report with the detailed profiles of the key players operating in the market.
๐๐จ๐ฆ๐ ๐จ๐ ๐ญ๐ก๐๐ฌ๐ ๐ค๐๐ฒ ๐ฉ๐ฅ๐๐ฒ๐๐ซ๐ฌ ๐ข๐ง๐๐ฅ๐ฎ๐๐:
โข Abbott Laboratories
โข AstraZeneca plc
โข CSL Limited
โข Daiichi Sankyo Company Limited
โข Emergent BioSolutions Inc.
โข F. Hoffmann-La Roche AG
โข Gamma Vaccines Pty Ltd
โข GlaxoSmithKline plc
โข Merck & Co. Inc.
โข Novartis AG
โข Pfizer Inc.
โข Sanofi
โข SINOVAC
Key Market Segmentation:
The report has segmented the influenza vaccine market on the basis of breakup by vaccine type, technology, age group, route of administration and region.
Breakup by Vaccine Type:
โข Quadrivalent
โข Trivalent
Breakup by Technology:
โข Egg-based
โข Cell-based
Breakup by Age Group:
โข Pediatric
โข Adult
Breakup by Route of Administration:
โข Injection
โข Nasal Spray
Breakup by Region:
โข North America (United States, Canada)
โข Europe (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
โข Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, Others)
โข Latin America (Brazil, Mexico, Others)
โข Middle East and Africa (United Arab Emirates, Saudi Arabia, Turkey, South Africa, Others)
๐๐ฌ๐ค ๐๐ง๐๐ฅ๐ฒ๐ฌ๐ญ ๐๐จ๐ซ ๐๐ฎ๐ฌ๐ญ๐จ๐ฆ๐ข๐ณ๐๐ญ๐ข๐จ๐ง ๐๐ง๐ ๐๐ฑ๐ฉ๐ฅ๐จ๐ซ๐ ๐ ๐ฎ๐ฅ๐ฅ ๐๐๐ฉ๐จ๐ซ๐ญ ๐๐ข๐ญ๐ก ๐๐๐ & ๐๐ข๐ฌ๐ญ ๐จ๐ ๐ ๐ข๐ ๐ฎ๐ซ๐๐ฌ: https://www.imarcgroup.com/request?type=report&id=4206&flag=C
Key Highlights of the Report:
โข Market Performance (2016-2021)
โข Market Outlook (2022-2027)
โข Market Trends
โข Market Drivers and Success Factors
โข Impact of COVID-19
โข Value Chain Analysis
โข Comprehensive mapping of the competitive landscape
If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.
๐๐ซ๐จ๐ฐ๐ฌ๐ ๐๐จ๐ซ๐ ๐๐๐ฅ๐๐ญ๐๐ ๐๐๐ฉ๐จ๐ซ๐ญ๐ฌ:
About Us
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARCโs information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the companyโs expertise.
Our offerings include comprehensive market intelligence in the form of research reports, production cost reports, feasibility studies, and consulting services. Our team, which includes experienced researchers and analysts from various industries, is dedicated to providing high-quality data and insights to our clientele, ranging from small and medium businesses to Fortune 1000 corporations.
Elena Anderson
IMARC Services Private Limited
+1 631-791-1145
email us here